Takahiro Yoshizawa

Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy

Ryo Ariyasu, Atsushi Horiike, Takahiro Yoshizawa et al. · Anticancer Research · 2017 · 50 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer

Tsukasa Hasegawa, Noriko Yanagitani, Hirofumi Utsumi et al. · Anticancer Research · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · BMC Cancer · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · Lung Cancer · 2020 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +11

Simultaneous modified Camitz opponensplasty using a pulley at the radial side of the flexor retinaculum in severe carpal tunnel syndrome

Naoki Kato, Takahiro Yoshizawa, Hiroya Sakai · Journal of Hand Surgery (European Volume) · 2013 · 34 citations

Medicine, Orthopaedic Surgery, Surgery +7